⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AGEN News
Agenus Inc.
Frankreich erweitert den nationalen AAC-Zugang für Botensilimab und Balstilimab von Agenus zur Behandlung von Eierstockkrebs und Weichteilsarkomen
businesswire.com
AGEN
Frankrijk breidt nationale AAC-toegang uit voor Agenus' botensilimab + balstilimab voor eierstokkanker en wekedelensarcomen
businesswire.com
AGEN
法國擴大Agenus用於治療卵巢癌和軟組織肉瘤的Botensilimab + Balstilimab組合療法的國家同情用藥授權範圍
businesswire.com
AGEN
法国扩大Agenus用于治疗卵巢癌和软组织肉瘤的Botensilimab + Balstilimab组合疗法的国家同情用药授权范围
businesswire.com
AGEN
La Francia espande l'accesso nazionale all'AAC per botensilimab + balstilimab di Agenus per il carcinoma ovarico e i sarcomi dei tessuti molli
businesswire.com
AGEN
France Expands National AAC Access for Agenus' Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas
businesswire.com
AGEN
NanOlogy Appoints John M. Goldberg, MD as Chief Medical Officer to Further its Preclinical & Clinical Large Surface Area Microparticle Investigational Drug Portfolio
prnewswire.com
AGEN
Agenus Reports Deep, Durable Responses with Botensilimab + Balstilimab in Highly Refractory Ovarian Cancer, Published in JITC
businesswire.com
AGEN
GI Cancer Immunotherapy Breakthroughs Signal New Treatment Era
globenewswire.com
ONCY
AGEN
CRDF
EXEL
GILD
Empowering Better Outcomes: Mediaplanet Launches "Breast Health" Campaign
prnewswire.com
GEHC
AZN
SYK
AGEN